Skip to main content
ACOG logo

Alpha Cognition Inc (ACOG) Stock Price & Analysis

Alpha Cognition Inc (ACOG) — MoonshotScore 30/100 (Weak band), calculated Nov 18, 2026. Price $8.85 (+2.91%), as of the Nov 19, 2026 trading session; market cap $195M.

Educational signal · not a buy or sell recommendation · How to read this

$8.85 +$0.25 (+2.91%) Market Cap $195M

Alpha Cognition Inc · ACOG · NASDAQ

Alpha Cognition Inc. is a clinical stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease and ALS. With a strong product pipeline, including ZUNVEYL, the company aims to address critical unmet medical needs in neurodegenerative diseases.

Price as of Nov 19, 2026

Key Statistics

30 of 100

MoonshotScore v2 · Alpha Cognition (ACOG)

Weak
Business Quality Thin (21)
Financial Safety Okay (55)
Valuation Rich (38)
Growth Durability Fading (35)
Momentum Surging (82)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Strong price action running well ahead of the business — bottom-tier quality underneath; a move to treat with suspicion, not chase. The score also carries a risk penalty for losses on top of negative retained earnings. Business Quality: Thin; Financial Safety: Okay; Valuation: Rich; Growth Durability: Fading; Momentum: Surging.

  • quarterly revenue $8M (Q3 FY2026, quarter ended Sep 2026)
  • EPS beat 0 of the last 5 reports
  • Altman Z 4.56 · Piotroski F 3

Holding back: weak fundamentals

Helping: positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for ACOG (58 recorded, newest six shown)
RecordedScoreBand
30Weak
30Weak
30Weak
30Weak
30Weak
30Weak

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$8.85
Change on the day+2.91%
52-week range$4.50 – $10.14
Market capitalisation$195M—
Price / earnings (trailing)-4.75
Shares traded on the day108.1K

Price & events

Other perspectives

Council score for Alpha Cognition (ACOG): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Weak
Financial Safety Neutral
Valuation Weak
Growth Durability Weak
Momentum Strong

Legends Council

3 lenses, 3 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Englander-style lens (simulated) Izzy Englander Unfavorable read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Unfavorable read

Read on: Nov 21, 2026

Munger's Mindset

Balance Sheet & Valuation

Financial Health Weak
Margin of Safety Fairly Valued
Profit Margin Weak
Revenue Growth Weak
ROE Negative
Gross Margin Strong

Read on: Nov 20, 2026

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

The Munger lens reads the current price as fairly valued against its own estimate of value.

Readings on this page are from Nov 21, 2026, except a card that shows its own read date.

1 · What is it?

What is Alpha Cognition (ACOG), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Alpha Cognition Inc (ACOG) is listed on NASDAQ. It employs 71 people and is led by Michael E. McFadden. In Q3 FY2026 it reported revenue of $8M and net income of -$8M. The market values it at $195M.

2 · Latest results

What do the latest results show for Alpha Cognition (ACOG)?

Short answer · as of

The most recent reported quarter, Q3 FY2026, carried revenue of $8M. Against analyst estimates the company has EPS beat 0 of the last 5 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q3 FY2026$8M-$8M-$0.35 (diluted)
Q2 FY2026$6M-$9M-$0.40 (diluted)
Q1 FY2026$4M-$6M-$0.30 (diluted)
Q4 FY2025$3M-$7M-$0.31 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Alpha Cognition (ACOG)?

Short answer · as of

The MoonshotScore pillars rate positive momentum as strengths. What is holding it back is weak fundamentals. The distress and quality screens read Altman Z 4.56 · Piotroski F 3. Trailing ratios: ROE -67.6% · ROA -32.4% · current ratio 7.13.

Data-derived red flags

  • Negative return on equity (-67.6%) — the business is not currently generating profit on shareholder capital.
  • Inconsistent delivery — missed Wall Street EPS estimates in 0 of the last 5 reported quarters.
  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
4 · What to check next?

What should you watch next at Alpha Cognition (ACOG)?

Short answer · as of

The stored analyst-target capture is expired, so a current target watchpoint is unavailable.

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The next earnings date is not yet scheduled in the calendar we read.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does Alpha Cognition compare with its peers?

Short answer

Alpha Cognition's score ranks 13th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Fennec Pharmaceuticals Inc. (FENC) Same industry, near in market value$13.45 Nov 19, 2026$475M91 5-pillar Nov 18, 2026
Zevra Therapeutics, Inc. (ZVRA) Same industry, near in market value$9.07 Nov 19, 2026$540M91 5-pillar Nov 18, 2026
Protalix BioTherapeutics, Inc. (PLX) Same industry, near in market value$3.06 Nov 19, 2026$258M90 5-pillar Nov 18, 2026
Rigel Pharmaceuticals, Inc. (RIGL) Same industry, near in market value$41.19 Nov 19, 2026$776M88 5-pillar Nov 18, 2026
ImmuCell Corporation (ICCC) Same industry, near in market value$11.17 Nov 19, 2026$102M82 5-pillar Nov 18, 2026
Rallybio Corporation (RLYB) Same industry, near in market value$15.52 Nov 19, 2026$86.9M82 5-pillar Nov 18, 2026
Oramed Pharmaceuticals Inc. (ORMP) Same industry, near in market value$3.69 Nov 19, 2026$160M72 5-pillar Nov 18, 2026
Compugen Ltd. (CGEN) Same industry, near in market value$1.88 Nov 19, 2026$178M69 5-pillar Nov 18, 2026
Pharming Group N.V. (PHAR) Same industry, near in market value$12.17 Nov 19, 2026$861M69 5-pillar Nov 18, 2026
Climb Bio, Inc. (CLYM) Same industry, near in market value$9.28 Nov 19, 2026$545M68 5-pillar Nov 18, 2026
SpyGlass Pharma, Inc. Common Stock (SGP) Same industry, near in market value$30.78 Nov 19, 2026$1.03B64 5-pillar Nov 18, 2026
MeiraGTx Holdings plc (MGTX) Same industry, near in market value$8.14 Nov 19, 2026$796M63 5-pillar Nov 18, 2026
Alpha Cognition (ACOG) — this page$8.85$195M30

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Analyst targets & estimates

What analysts have on file

Last captured analyst target range, low to high (expired, captured Nov 18, 2026)
$12.00 – $21.00
Last captured analyst target (expired, captured Nov 18, 2026)
$17.50
Last captured median analyst target (expired, captured Nov 18, 2026)
$18.50

Historical target record · Captured · Capture expired; not a current watchpoint.

Insider activity

Form 4 records via FMP · Of the newest 500 records, those within the last 180 days, newest dated Nov 11, 2026

Transactions
31
Identified insiders
3
Purchases
29
Sales
0
Other transactions
2

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held ACOG in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported ACOG in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Alpha Cognition (ACOG)?

Read these with our analysis →

Investor Questions: ACOG Stock

These answers are editorial: 1 of these 9 answers is drawn from the ACOG research dossier (written May 10, 2026 by gpt-4o-mini); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for ACOG?

ACOG carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. Alpha Cognition Inc. is a clinical stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease and ALS.

Is ACOG a good stock to buy?

Stock Expert AI does not rate ACOG buy, sell or hold. Alpha Cognition Inc carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the ACOG stock price today?

The last price recorded for Alpha Cognition Inc (ACOG), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the ACOG price target?

The last analyst consensus price target we captured for Alpha Cognition Inc (ACOG), with its FMP capture date, is listed under Analyst targets & estimates on this page. That capture has expired, so read it as historical, not as a current target. Targets are analyst opinions, not a Stock Expert AI forecast.

What are the main risks for ACOG?

Alpha Cognition Inc. faces several risks, including regulatory hurdles that could delay product approvals and impact market entry. Additionally, the company operates with a negative profit margin, which raises concerns about financial stability and the ability to fund ongoing clinical trials.

What are the key factors to evaluate for ACOG?

Alpha Cognition Inc (ACOG) holds a MoonshotScore in the low range. Lead product ZUNVEYL targets a significant market segment with growing demand for Alzheimer's treatments. Not financial advice.

How frequently does ACOG data refresh on this page?

ACOG's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven ACOG's recent stock price performance?

Alpha Cognition Inc (ACOG) moves on earnings results, analyst revisions, sector rotation, and market sentiment. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider ACOG overvalued or undervalued right now?

Alpha Cognition Inc (ACOG) is loss-making, so its trailing P/E (listed under Price & valuation) is negative and not usable for valuation — lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Machine-generated analysis by Stock Expert AI — model gpt-4o-mini, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 20 figures on this page — 14 from Financial Modeling Prep (FMP), 5 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.